Prospera Financial Services Inc boosted its position in CVS Health Corporation (NYSE:CVS) by 6.8% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 3,771 shares of the pharmacy operator’s stock after buying an additional 241 shares during the period. Prospera Financial Services Inc’s holdings in CVS Health Corporation were worth $361,000 as of its most recent SEC filing.
Other institutional investors have also recently bought and sold shares of the company. Atwood & Palmer Inc. boosted its stake in CVS Health Corporation by 1.5% in the second quarter. Atwood & Palmer Inc. now owns 202,127 shares of the pharmacy operator’s stock worth $19,352,000 after buying an additional 3,059 shares in the last quarter. TIAA CREF Trust Co. FSB MO boosted its stake in CVS Health Corporation by 2.5% in the second quarter. TIAA CREF Trust Co. FSB MO now owns 200,005 shares of the pharmacy operator’s stock worth $19,149,000 after buying an additional 4,913 shares in the last quarter. Sentry Investments Corp. boosted its stake in CVS Health Corporation by 6.3% in the first quarter. Sentry Investments Corp. now owns 2,179,600 shares of the pharmacy operator’s stock worth $226,090,000 after buying an additional 128,300 shares in the last quarter. Lodestar Investment Counsel LLC IL boosted its stake in CVS Health Corporation by 4.2% in the second quarter. Lodestar Investment Counsel LLC IL now owns 176,387 shares of the pharmacy operator’s stock worth $16,887,000 after buying an additional 7,136 shares in the last quarter. Finally, Scharf Investments LLC boosted its stake in CVS Health Corporation by 4.2% in the first quarter. Scharf Investments LLC now owns 1,914,846 shares of the pharmacy operator’s stock worth $198,627,000 after buying an additional 76,797 shares in the last quarter. Institutional investors and hedge funds own 80.96% of the company’s stock.
CVS Health Corporation (NYSE:CVS) traded up 0.34% during trading on Thursday, reaching $86.49. The company’s stock had a trading volume of 5,267,005 shares. The stock has a 50-day moving average of $91.72 and a 200 day moving average of $97.02. CVS Health Corporation has a one year low of $85.89 and a one year high of $106.67. The firm has a market capitalization of $92.22 billion, a P/E ratio of 19.90 and a beta of 0.83.
CVS Health Corporation (NYSE:CVS) last posted its quarterly earnings data on Tuesday, August 2nd. The pharmacy operator reported $1.32 EPS for the quarter, topping analysts’ consensus estimates of $1.30 by $0.02. CVS Health Corporation had a net margin of 2.88% and a return on equity of 15.86%. The firm earned $43.70 billion during the quarter, compared to analyst estimates of $44.28 billion. During the same quarter last year, the business posted $1.19 EPS. The company’s revenue was up 17.6% on a year-over-year basis. On average, equities research analysts predict that CVS Health Corporation will post $5.86 EPS for the current fiscal year.
The company also recently disclosed a quarterly dividend, which will be paid on Thursday, November 3rd. Investors of record on Monday, October 24th will be paid a $0.425 dividend. This represents a $1.70 dividend on an annualized basis and a yield of 1.97%. The ex-dividend date is Thursday, October 20th. CVS Health Corporation’s dividend payout ratio is 39.08%.
CVS has been the topic of a number of recent research reports. Argus reissued a “buy” rating and issued a $120.00 target price on shares of CVS Health Corporation in a research note on Thursday, August 4th. Mizuho increased their price objective on CVS Health Corporation from $108.00 to $111.00 and gave the company a “buy” rating in a research report on Thursday, August 4th. Leerink Swann reaffirmed a “buy” rating on shares of CVS Health Corporation in a research report on Wednesday, August 3rd. Jefferies Group reaffirmed a “buy” rating on shares of CVS Health Corporation in a research report on Monday, July 4th. Finally, Credit Suisse Group AG reaffirmed a “buy” rating and set a $115.00 price objective on shares of CVS Health Corporation in a research report on Tuesday, September 20th. Six equities research analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has assigned a strong buy rating to the company. The company presently has an average rating of “Buy” and a consensus price target of $112.11.
About CVS Health Corporation
CVS Health Corporation, together with its subsidiaries (CVS Health), is a pharmacy company. The Company operates through three business segments: Pharmacy Services, Retail/LTC and Corporate. The Company offers a range of products and services, such as advising patients on their medications at its CVS Pharmacy locations, introducing programs to help control costs for its clients at CVS Caremark, how care is delivered to its patients with conditions through CVS Specialty, pharmacy care for the senior community through Omnicare.
Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corporation (NYSE:CVS).
Receive News & Ratings for CVS Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health Corporation and related companies with MarketBeat.com's FREE daily email newsletter.